Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:


Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,700,128

« Back to Dashboard

Which drugs does patent 7,700,128 protect, and when does it expire?

Patent 7,700,128 protects DUETACT and is included in one NDA. There has been one Paragraph IV challenge on Duetact.

This patent has twenty-nine patent family members in twenty-six countries.

Summary for Patent: 7,700,128

Title:Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
Abstract:A solid preparation useful as a diabetes-treating agent or the like and excellent in the dissolution properties of an insulin sensitizer and an insulin secretagogue, which comprises an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester is provided.
Inventor(s): Doken; Kazuhiro (Osaka, JP), Kawano; Tetsuya (Osaka, JP), Koyama; Hiroyoshi (Osaka, JP), Hamaguchi; Naoru (Osaka, JP)
Assignee: Takeda Pharmaceutical Company Limited (Osaka, JP)
Application Number:10/544,581
Patent Claim Types:
see list of patent claims

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Takeda Pharms UsaDUETACTglimepiride; pioglitazone hydrochlorideTABLET;ORAL021925-001Jul 28, 2006ABRXYesYes► Subscribe► SubscribeY► Subscribe
Takeda Pharms UsaDUETACTglimepiride; pioglitazone hydrochlorideTABLET;ORAL021925-002Jul 28, 2006ABRXYesNo► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 7,700,128

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2003-371679Oct 31, 2003
PCT Information
PCT FiledOctober 21, 2004PCT Application Number:PCT/JP2004/015958
PCT Publication Date:May 12, 2005PCT Publication Number: WO2005/041962

International Patent Family for Patent: 7,700,128

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina046210► Subscribe
Australia2004285354► Subscribe
BrazilPI0414979► Subscribe
Canada2540225► Subscribe
China1874774► Subscribe
Cyprus1117176► Subscribe
Denmark1677792► Subscribe
European Patent Office1677792► Subscribe
Spain2556244► Subscribe
Georgia, Republic ofP20084570► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Fish and Richardson
Cantor Fitzgerald
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: